J&J sees OTC rise in US as products return

23 January 2014 - Deborah Wilkes

Archived

Johnson & Johnson's OTC sales in the US increased by 19.7% to US$1.29 billion in 2013, as the company continued to return its recalled products to shelves.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: